English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Dear Editor, Calcium sulfate beads are increasingly used during revision orthopedic surgery as a vehicle for local antibiotic delivery [1]. They offer several advantages over polymethylmethacrylate (PMMA) beads as they are absorbable, are more efficient at local delivery of antibiotics, and lack the exothermic reaction often associated with PMMA, which allows them to be used with less heat-stable antibiotics. However, given the high efficiency of drug elution and their absorbability, calcium sulfate beads carry the risk of both antibiotic toxicity and hypercalcemia. There is limited literature available regarding the risk of hypercalcemia associated with calcium sulfate beads. We present a case of hypercalcemia and antibiotic-related acute kidney injury following implantation of antibiotic impregnated calcium sulfate beads. This case study did not require Institutional Review Board approval. A 90-year-old woman with a medical history of atrial fibrillation presented to the Mayo Clinic Hospital in Rochester, USA, in February 2017 following a fall during which she sustained a left trochanteric fracture. She underwent open reduction and internal fixation surgery that was complicated by atrophic nonunion requiring revision with exchange of hardware in June 2017. Her postoperative course was further complicated by a deep surgical site infection with methicillin-susceptible Staphylococcus aureus and Enterobacter cloacae. On January 1, 2018, she underwent hardware removal, irrigation and debridement, and placement of PMMA beads loaded with 4.8 g of gentamicin and 4 g of vancomycin. Five days later, the PMMA beads were removed, and an intramedullary rod was implanted along with calcium sulfate beads loaded with 7.2 g of gentamicin and 6 g of vancomycin. She did well during the immediate postoperative period and was discharged to a rehabilitation facility. On January 13, 2018, the patient was hospitalized with acute confusion, worsened renal function (WRF) with a creatinine level of 360 μmol/L that had increased from a baseline of 80 μmol/L, and a serum calcium level of 3.44 mmol/L (corrected for hypoalbuminemia). Further evaluation revealed appropriately suppressed parathyroid hormone (PTH) of 7.2 ng/L, PTH related peptide of 3.7 pg/L, normal 25-hydroxy vitamin D and 1,25-hydroxy vitamin D levels, and normal serum protein electrophoresis. A renal ultrasound excluded post-renal obstruction, and the urinalysis was bland without casts. A computed tomography scan of the lower extremity revealed accelerated resolution of the absorbable calcium sulfate beads. Her random gentamicin level one week after surgery was 6.1 μmol/L (the toxic trough level is considered >4.2 μmol/L), and her random serum vancomycin level was 19.6 μmol/L. These

A Case of Hypercalcemia and Antibiotic-Related Acute Kidney Injury Following Implantation of Antibiotic Impregnated Calcium Sulfate Beads